Showing results for "BetterLife Pharma"
business
Investors Are Seeing IPOs As a Viable Asset Class Again, JPMorgan SaysHi, it’s Ryan Gould, on my way to Berlin for SuperReturn. But first, I’m bringing you the best bits from a recent chat on the transitional state of IPOs with JPMorgan’s Americas ECM head. We also have the latest on the pursuit of Paramount.June 3, 2024
technology
Blackstone Is Said to Consider Sale of $1.9 Billion Alinamin PharmaceuticalBlackstone Inc. is considering a sale of Japanese consumer health-care firm Alinamin Pharmaceutical Co., which used to be owned by Takeda Pharmaceutical Co., according to people familiar with the situation.June 3, 2024